Clinical Evaluation of Platelet Rich Fibrin Versus Subepithelial Connective Tissue Graft for Soft Tissue Augmentation

N/AUnknownNCT03219944

Cairo University16 enrolled

Overview

Soft tissue biotype is a critical factor for success of implant in the esthetic zone . Different soft tissue augmentation techniques have been employed to increase soft tissue thickness such as: autogenous grafts, allografts, xenografts and living cellular construct (LCC). Studies showed that, allografts and xenografts were inferior when compared with autogenous graft . However, few studies were conducted to evaluate the efficacy of soft tissue augmentation with platelet rich fibrin in order to overcome the patient morbidity with SCTG.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

SINGLE

Enrollment

Conditions

Patients With at Least Single Missing Anterior Tooth Thin Gingival Biotype

Interventions

: Platelet Rich Fibrin for soft tissue augmentation around implant in the aesthetic zone

sub epithelial connective tissue graftPROCEDURE

sub epithelial connective tissue graft for soft tissue augmentation around implant in the aesthetic zone

Eligibility

Sex: ALLMin age: 20 YearsMax age: 60 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: 1. Patients with missing maxillary anterior toot teeth. 2. Thin gingival biotype. 3. Adequate inter-arch space for placement of the implant prosthetic part. 4. Good oral hygiene where gingival index is (0, 1) (Loe and Silness 1963). Exclusion Criteria: 1. Patient with medical condition that is contraindicated with the surgical procedure 2. Patients receiving treatment that affect the healing ability. 3. Patients with local pathological defects related to the area of interest. 4. Smokers or pregnant women. 5. Patients with parafunctional habits that may jeopardize the implant longevity and affect the results of the study.

Locations (1)

Maymohamedkamal

Cairo, Elmaniel, Egypt

Outcomes

Primary Outcomes

Crestal bone resorption

measured mesially and distally using periapical xray in mm

Time frame: 6 months

Central Contacts

may mo kamal

CONTACT

01063392983 maykamalmo@gmail.com

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.